{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T05:09:57Z","timestamp":1784956197985,"version":"3.55.0"},"reference-count":32,"publisher":"Oxford University Press (OUP)","issue":"13","license":[{"start":{"date-parts":[[2023,7,6]],"date-time":"2023-07-06T00:00:00Z","timestamp":1688601600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key R&D Program of China","doi-asserted-by":"publisher","award":["2018YFC1315303"],"award-info":[{"award-number":["2018YFC1315303"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Projects in the Chinese National Science & Technology Pillar Program","award":["2011BAI11B01"],"award-info":[{"award-number":["2011BAI11B01"]}]},{"DOI":"10.13039\/501100012167","name":"National Key Research and Development Program","doi-asserted-by":"publisher","award":["2017YFC1307603"],"award-info":[{"award-number":["2017YFC1307603"]}],"id":[{"id":"10.13039\/501100012167","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012167","name":"National Key Research and Development Program","doi-asserted-by":"publisher","award":["2016YFC1301305"],"award-info":[{"award-number":["2016YFC1301305"]}],"id":[{"id":"10.13039\/501100012167","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012167","name":"National Key Research and Development Program","doi-asserted-by":"publisher","award":["2017YFC0909303"],"award-info":[{"award-number":["2017YFC0909303"]}],"id":[{"id":"10.13039\/501100012167","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012829","name":"Climbing Plan of Guangdong Provincial People's Hospital","doi-asserted-by":"publisher","award":["DFJH2020022"],"award-info":[{"award-number":["DFJH2020022"]}],"id":[{"id":"10.13039\/100012829","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Guangdong Provincial Clinical Research Center for Cardiovascular Disease","award":["2020B1111170011"],"award-info":[{"award-number":["2020B1111170011"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,9,20]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Aims<\/jats:title>\n                  <jats:p>There are no nationwide epidemiological data on heart failure (HF) stages in China. Knowledge of the prevalence of HF stages is crucial for planning HF prevention and management strategies. We aimed to evaluate the prevalence of HF stages in the general Chinese population and the specific prevalence by age, sex, and urbanity.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods and results<\/jats:title>\n                  <jats:p>This is a cross-sectional study and national representative general population aged \u2265 35 years (n = 31 494, mean age 57.4 years, women 54.1%) were obtained from the China Hypertension Survey. Participants were divided into Stage A (at-risk for HF), Stage B (pre-HF), and Stage C (symptomatic HF). Survey weights were calculated based on the 2010 China population census data. The prevalence of Stage A was 35.8% (\u2248245.1 million), Stage B 42.8% (\u2248293.1 million), and Stage C 1.1% (\u22487.5 million). The prevalence of Stages B and C increased with increasing age (P &amp;lt; 0.0001). Women had lower prevalence of Stage A (32.6% vs. 39.3%; P &amp;lt; 0.0001) but higher prevalence of Stage B (45.9% vs. 39.5%; P &amp;lt; 0.0001) than men. People from rural area had lower prevalence of Stage A (31.9% vs. 41.0%; P &amp;lt; 0.0001) but higher prevalence of Stage B (47.8% vs. 36.2%; P &amp;lt; 0.0001) than people from urban. The prevalence of Stage C was similar by sex and urbanity.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>The burdens of pre-clinical and clinical HF are high and vary by age, sex, and urbanity in China. Targeted interventions are needed to reduce the high burden of pre-clinical and clinical HF.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/eurjpc\/zwad223","type":"journal-article","created":{"date-parts":[[2023,7,6]],"date-time":"2023-07-06T16:22:35Z","timestamp":1688660555000},"page":"1391-1400","source":"Crossref","is-referenced-by-count":29,"title":["Prevalence of heart failure stages in the general population and implications for heart failure prevention: reports from the China Hypertension Survey 2012\u201315"],"prefix":"10.1093","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3953-5881","authenticated-orcid":false,"given":"Anping","family":"Cai","sequence":"first","affiliation":[{"name":"Department of Cardiology, Hypertension Research Laboratory, Guangdong Cardiovascular Institute, Guangdong Provincial People\u2019s Hospital, Guangdong Academy of Medical Sciences, Southern Medical University , No.106, Zhongshan 2nd Road, Yuexiu District, Guangzhou 510080 , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Congyi","family":"Zheng","sequence":"additional","affiliation":[{"name":"Division of Prevention and Community Health, National Center for Cardiovascular Disease, Fuwai Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences , No. 15 (Lin), Fengcunxili, Mentougou District, Beijing 102308 , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiayuan","family":"Qiu","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, School of Public Health, Medical College of Soochow University , Suzhou 201701 , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3192-8093","authenticated-orcid":false,"given":"Gregg C","family":"Fonarow","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Medicine, Geffen School of Medicine at UCLA , Los Angeles, CA , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory Y H","family":"Lip","sequence":"additional","affiliation":[{"name":"Liverpool Centre for Cardiovascular Science at University of Liverpool, Liverpool John Moores University and Liverpool Heart & Chest Hospital , Liverpool , UK"},{"name":"Danish Center for Clinical Health Services Research, Department of Clinical Medicine, Aalborg University , Aalborg , Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingqing","family":"Feng","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Hypertension Research Laboratory, Guangdong Cardiovascular Institute, Guangdong Provincial People\u2019s Hospital, Guangdong Academy of Medical Sciences, Southern Medical University , No.106, Zhongshan 2nd Road, Yuexiu District, Guangzhou 510080 , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zengwu","family":"Wang","sequence":"additional","affiliation":[{"name":"Division of Prevention and Community Health, National Center for Cardiovascular Disease, Fuwai Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences , No. 15 (Lin), Fengcunxili, Mentougou District, Beijing 102308 , China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2023,7,6]]},"reference":[{"key":"2023092217530651100_zwad223-B1","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1016\/S0140-6736(18)32279-7","article-title":"Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990\u20132017: a systematic analysis for the Global Burden of Disease Study 2017","volume":"392","author":"GBD 2017 Disease and Injury Incidence and Prevalence Collaborators","year":"2018","journal-title":"Lancet"},{"key":"2023092217530651100_zwad223-B2","doi-asserted-by":"crossref","first-page":"e008406","DOI":"10.1161\/CIRCHEARTFAILURE.121.008406","article-title":"Prevalence and incidence of heart failure among urban patients in China: a national population-based analysis","volume":"14","author":"Wang","year":"2021","journal-title":"Circ Heart Fail"},{"key":"2023092217530651100_zwad223-B3","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1002\/ejhf.1629","article-title":"Prevalence of heart failure and left ventricular dysfunction in China: the China Hypertension Survey, 2012\u20132015","volume":"21","author":"Hao","year":"2019","journal-title":"Eur J Heart Fail"},{"key":"2023092217530651100_zwad223-B4","first-page":"352","article-title":"Universal definition and classification of heart failure: a report of the Heart Failure Society of America, Heart Failure Association of the European Society of Cardiology, Japanese Heart Failure Society and writing committee of the universal definition of heart failure","volume":"23","author":"Bozkurt","year":"2021","journal-title":"J Cardiac Fail"},{"key":"2023092217530651100_zwad223-B5","doi-asserted-by":"crossref","first-page":"e263","DOI":"10.1016\/j.jacc.2021.12.012","article-title":"2022 AHA\/ACC\/HFSA guideline for the management of heart failure: a report of the American College of Cardiology\/American Heart Association joint committee on clinical practice guidelines","volume":"79","author":"Heidenreich","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"2023092217530651100_zwad223-B6","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1177\/2047487320922636","article-title":"Prevalence and determinants of the precursor stages of heart failure: results from the population-based STAAB cohort study","volume":"28","author":"Morbach","year":"2021","journal-title":"Eur J Prev Cardiol"},{"key":"2023092217530651100_zwad223-B7","doi-asserted-by":"crossref","first-page":"e005730","DOI":"10.1161\/CIRCHEARTFAILURE.118.005730","article-title":"Prevalence of American Heart Association heart failure stages in Black and White young and middle-aged adults: the CARDIA study","volume":"12","author":"Gidding","year":"2019","journal-title":"Circ Heart Fail"},{"key":"2023092217530651100_zwad223-B8","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1161\/CIRCULATIONAHA.116.023361","article-title":"Heart failure stages among older adults in the community: the atherosclerosis risk in communities study","volume":"135","author":"Shah","year":"2017","journal-title":"Circulation"},{"key":"2023092217530651100_zwad223-B9","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.1002\/ejhf.2654","article-title":"Clinical characteristics and 1-year outcomes in hospitalized patients with heart failure with preserved ejection fraction: results from the China Cardiovascular Association Database-Heart Failure Center Registry","volume":"24","author":"Cai","year":"2022","journal-title":"Eur J Heart Fail"},{"key":"2023092217530651100_zwad223-B10","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1161\/CIRCULATIONAHA.117.032380","article-title":"Status of hypertension in China: results from the China Hypertension Survey, 2012\u20132015","volume":"137","author":"Wang","year":"2018","journal-title":"Circulation"},{"key":"2023092217530651100_zwad223-B11","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.echo.2008.11.023","article-title":"Recommendations for the evaluation of left ventricular diastolic function by echocardiography","volume":"22","author":"Nagueh","year":"2009","journal-title":"J Am Soc Echocardiogr"},{"key":"2023092217530651100_zwad223-B12","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","article-title":"2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"42","author":"McDonagh","year":"2021","journal-title":"Eur Heart J"},{"key":"2023092217530651100_zwad223-B13","volume-title":"Tabulation on the 2010 population census on the People\u2019s Republic of China","author":"Census Office of the State Council of China, Division of Population and Employment Statistics, National Bureau of Statistics of China","year":"2012"},{"key":"2023092217530651100_zwad223-B14","doi-asserted-by":"crossref","first-page":"10237","DOI":"10.1038\/s41598-020-66084-9","article-title":"Prevalence of diabetes mellitus and its associated factors in Bangladesh: application of two-level logistic regression model","volume":"10","author":"Talukder","year":"2020","journal-title":"Sci Rep"},{"key":"2023092217530651100_zwad223-B15","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1056\/NEJMoa2105675","article-title":"Effect of salt substitution on cardiovascular events and death","volume":"385","author":"Neal","year":"2021","journal-title":"N Engl J Med"},{"key":"2023092217530651100_zwad223-B16","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/s12966-021-01138-3","article-title":"The effect of social media interventions on physical activity and dietary behaviours in young people and adults: a systematic review","volume":"18","author":"Goodyear","year":"2021","journal-title":"Int J Behav Nutr Phys Act"},{"key":"2023092217530651100_zwad223-B17","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1016\/j.jacc.2016.11.076","article-title":"Adherence to healthy lifestyle and cardiovascular diseases in the Chinese population","volume":"69","author":"Lv","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"2023092217530651100_zwad223-B18","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1038\/s41569-020-0371-2","article-title":"Environmental determinants of cardiovascular disease: lessons learned from air pollution","volume":"17","author":"Al-Kindi","year":"2020","journal-title":"Nat Rev Cardiol"},{"key":"2023092217530651100_zwad223-B19","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1002\/ejhf.2351","article-title":"Preventing heart failure: a position paper of the Heart Failure Association in collaboration with the European Association of Preventive Cardiology","volume":"24","author":"Piepoli","year":"2022","journal-title":"Eur J Heart Fail"},{"key":"2023092217530651100_zwad223-B20","first-page":"577","article-title":"Recommendations on the use of echocardiography in adult hypertension: a report from the European Association of Cardiovascular Imaging (EACVI) and the American Society of Echocardiography (ASE)\u2020","volume":"16","author":"Marwick","year":"2015","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"2023092217530651100_zwad223-B21","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1097\/HJH.0000000000003127","article-title":"Influences of achieved SBP on age and sex-related left ventricular structural alteration in community hypertensive populations","volume":"40","author":"Cai","year":"2022","journal-title":"J Hypertens"},{"key":"2023092217530651100_zwad223-B22","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1161\/CIRCULATIONAHA.110.937821","article-title":"Correlates of echocardiographic indices of cardiac remodeling over the adult life course: longitudinal observations from the Framingham Heart Study","volume":"122","author":"Cheng","year":"2010","journal-title":"Circulation"},{"key":"2023092217530651100_zwad223-B23","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.jchf.2016.11.014","article-title":"Fitness in young adulthood and long-term cardiac structure and function: the CARDIA study","volume":"5","author":"Pandey","year":"2017","journal-title":"JACC Heart Fail"},{"key":"2023092217530651100_zwad223-B24","doi-asserted-by":"crossref","first-page":"3421","DOI":"10.1093\/eurheartj\/ehaa419","article-title":"A randomized controlled trial of dapagliflozin on left ventricular hypertrophy in people with type two diabetes: the DAPA-LVH trial","volume":"41","author":"Brown","year":"2020","journal-title":"Eur Heart J"},{"key":"2023092217530651100_zwad223-B25","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1161\/CIRCULATIONAHA.119.042375","article-title":"Effect of empagliflozin on left ventricular mass in patients with type 2 diabetes mellitus and coronary artery disease: the EMPA-HEART CardioLink-6 randomized clinical trial","volume":"140","author":"Verma","year":"2019","journal-title":"Circulation"},{"key":"2023092217530651100_zwad223-B26","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1056\/NEJMoa1812389","article-title":"Dapagliflozin and cardiovascular outcomes in type 2 diabetes","volume":"380","author":"Wiviott","year":"2019","journal-title":"N Engl J Med"},{"key":"2023092217530651100_zwad223-B27","doi-asserted-by":"crossref","first-page":"3308","DOI":"10.1093\/eurheartj\/ehx525","article-title":"The effect of sacubitril\/valsartan compared to olmesartan on cardiovascular remodelling in subjects with essential hypertension: the results of a randomized, double-blind, active-controlled study","volume":"38","author":"Schmieder","year":"2017","journal-title":"Eur Heart J"},{"key":"2023092217530651100_zwad223-B28","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1093\/eurjpc\/zwaa147","article-title":"Burden of heart failure and underlying causes in 195 countries and territories from 1990 to 2017","volume":"28","author":"Bragazzi","year":"2021","journal-title":"Eur J Prev Cardiol"},{"key":"2023092217530651100_zwad223-B29","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1001\/jama.2023.2020","article-title":"Heart failure with preserved ejection fraction: a review","volume":"329","author":"Redfield","year":"2023","journal-title":"JAMA"},{"key":"2023092217530651100_zwad223-B30","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1056\/NEJMoa2107038","article-title":"Empagliflozin in heart failure with a preserved ejection fraction","volume":"385","author":"Anker","year":"2021","journal-title":"N Engl J Mede"},{"key":"2023092217530651100_zwad223-B31","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1056\/NEJMoa2206286","article-title":"Dapagliflozin in heart failure with mildly reduced or preserved ejection fraction","volume":"387","author":"Solomon","year":"2022","journal-title":"N Engl J Med"},{"key":"2023092217530651100_zwad223-B32","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1038\/s41591-021-01536-x","article-title":"The SGLT2 inhibitor dapagliflozin in heart failure with preserved ejection fraction: a multicenter randomized trial","volume":"27","author":"Nassif","year":"2021","journal-title":"Nat Med"}],"container-title":["European Journal of Preventive Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/eurjpc\/advance-article-pdf\/doi\/10.1093\/eurjpc\/zwad223\/50874871\/zwad223.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eurjpc\/article-pdf\/30\/13\/1391\/51717171\/zwad223.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eurjpc\/article-pdf\/30\/13\/1391\/51717171\/zwad223.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,22]],"date-time":"2023-09-22T17:53:52Z","timestamp":1695405232000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurjpc\/article\/30\/13\/1391\/7220555"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,6]]},"references-count":32,"journal-issue":{"issue":"13","published-online":{"date-parts":[[2023,7,6]]},"published-print":{"date-parts":[[2023,9,20]]}},"URL":"https:\/\/doi.org\/10.1093\/eurjpc\/zwad223","relation":{},"ISSN":["2047-4873","2047-4881"],"issn-type":[{"value":"2047-4873","type":"print"},{"value":"2047-4881","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,9]]},"published":{"date-parts":[[2023,7,6]]}}}